NTRBNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends January 31
NutriBand Inc.
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 4, 2026
$6.00−0.22 (-3.54%)
Close on Oct 19, 2026
- Market cap
- $72.94M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.48 (−19.79%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
NutriBand Inc. saw revenue fall 37.3% to $1.62M over the twelve months to Jul 31, 2026. Free cash flow was -$5.14M.
Revenue
$1.62M
-37.3% vs. a year earlier
Operating income
-$7.05M
TTM Q2 2027
Free cash flow
-$5.14M
FY2026
EPS, diluted
-$0.57
TTM Q2 2027
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jul 31, 2026
Valuation
- Market cap
- $72.94M
- P/E ratio
- –
- Price to sales
- 45.09
- Price to book
- 13.69
- Dividend yield
- –
- Free cash flow yield
- -7.05%
Fundamentals
- Revenue
- $1.62M
- Net income
- -$6.96M
- EPS, diluted
- -$0.57
- Free cash flow
- -$5.14M
- Book value per share
- $0.44
- Diluted shares
- 12M
Eleven years at a glance
Fiscal years 2016 to 2026 and trailing twelve months, USD
Revenue
$1.62M-37.3% YoY
Gross profit
$536.12K-39.5% YoY
Operating income
-$7.05M
Net income
-$6.96M
EPS, diluted
-$0.57
Free cash flow
–
Reported periodTrailing twelve months